RIGL

42.83

0.58% -0.25

Handel nachbörslich: 42.82 -0.010 -0.02%

Rigel Pharmaceuticals (RIGL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$43.08

Offen:

$42.91

24-Stunden-Volumen:

1.05M

Relative Volume:

1.79

Marktkapitalisierung:

$777.42M

Einnahmen:

$116.88M

Nettoeinkommen (Verlust:

$-25.09M

KGV:

-305.93

EPS:

-0.14

Netto-Cashflow:

$-20.74M

1W Leistung:

-2.53%

1M Leistung:

-15.17%

6M Leistung:

+119.87%

1J Leistung:

+160.05%

1-Tages-Spanne:

$41.54

$42.91

1-Wochen-Bereich:

$41.54

$44.85

52-Wochen-Spanne:

$15.50

$52.24

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Firmenname

Rigel Pharmaceuticals

Sektor

Healthcare (1131)

Branche

Biotechnology (632)

Telefon

650-624-1100

Adresse

611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA

Mitarbeiter

164

Twitter

@rigelpharma

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

RIGL's Discussions on Twitter

Vergleichen Sie RIGL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RIGL Rigel Pharmaceuticals	42.83	781.96M	116.88M	-25.09M	-20.74M	-0.14
VRTX Vertex Pharmaceuticals Inc	453.74	116.65B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	773.94	82.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	397.25	52.69B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	837.90	51.56B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	174.09	37.61B	447.02M	-1.18B	-906.14M	-6.1812

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-05	Hochstufung	Jefferies	Hold → Buy
2023-04-03	Fortgesetzt	Piper Sandler	Neutral
2022-06-09	Herabstufung	Citigroup	Buy → Neutral
2022-06-08	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2022-06-08	Herabstufung	Piper Sandler	Overweight → Neutral
2022-03-23	Eingeleitet	B. Riley Securities	Neutral
2020-11-09	Herabstufung	JP Morgan	Overweight → Neutral
2019-11-15	Fortgesetzt	Cantor Fitzgerald	Overweight
2019-09-26	Fortgesetzt	JP Morgan	Overweight
2019-03-01	Bestätigt	Cantor Fitzgerald	Overweight
2018-08-27	Eingeleitet	Citigroup	Buy
2018-05-02	Bestätigt	Cantor Fitzgerald	Overweight
2017-12-21	Fortgesetzt	Piper Jaffray	Overweight
2017-12-15	Eingeleitet	Cantor Fitzgerald	Overweight
2017-11-06	Fortgesetzt	H.C. Wainwright	Buy
2017-03-09	Bestätigt	H.C. Wainwright	Buy
2016-08-31	Bestätigt	H.C. Wainwright	Buy
2016-08-30	Bestätigt	Piper Jaffray	Overweight
2016-07-13	Eingeleitet	H.C. Wainwright	Buy
2016-06-13	Eingeleitet	Piper Jaffray	Overweight
2016-04-22	Hochstufung	JP Morgan	Neutral → Overweight
2013-04-08	Bestätigt	Stifel	Buy
2012-11-29	Eingeleitet	UBS	Neutral
2012-11-06	Bestätigt	Oppenheimer	Outperform
2012-03-26	Eingeleitet	Canaccord Genuity	Hold
2010-12-10	Herabstufung	MP Advisors	Outperform → Market Perform

Alle ansehen

Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten

06:58 AM

Range Financial Group LLC Makes New Investment in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

06:58 AM

Dec 28, 2025

With EPS Growth And More, Rigel Pharmaceuticals (NASDAQ:RIGL) Makes An Interesting Case - Yahoo Finance

Dec 28, 2025

Dec 27, 2025

Inspire Investing LLC Makes New $859,000 Investment in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

Dec 27, 2025

Dec 26, 2025

Momentum Shift: Will Rigel Pharmaceuticals Inc RI2 stock beat Nasdaq index returnsInsider Selling & Free Growth Oriented Trading Recommendations - moha.gov.vn

Dec 26, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Could Be 23% Below Their Intrinsic Value Estimate - 富途牛牛

Dec 26, 2025

Assenagon Asset Management S.A. Decreases Holdings in Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

Dec 26, 2025

Dec 25, 2025

(RIGL) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Dec 25, 2025

Dec 21, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Upgraded to Buy at Wall Street Zen - MarketBeat

Dec 21, 2025

Dec 20, 2025

Rigel Pharmaceuticals jumps on 2025 revenue guidance boost, Q3 beats - MSN

Dec 20, 2025

Dec 19, 2025

Can Rigel Pharmaceuticals Inc. stock deliver sustainable ROEJuly 2025 Snapshot & Weekly High Return Opportunities - Улправда

Dec 19, 2025

Will Rigel Pharmaceuticals Inc. stock benefit from automationEarnings Growth Report & Consistent Growth Stock Picks - DonanımHaber

Dec 19, 2025

How Rigel Pharmaceuticals Inc. stock compares to market leadersJuly 2025 Breakouts & High Accuracy Trade Alerts - DonanımHaber

Dec 19, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Dec 19, 2025

Dec 18, 2025

Is Rigel Pharmaceuticals Inc. stock near bottom after declineQuarterly Profit Review & Verified Short-Term Plans - Улправда

Dec 18, 2025

Behavioral Patterns of RIGL and Institutional Flows - news.stocktradersdaily.com

Dec 13, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat

Dec 13, 2025

Dec 12, 2025

Rigel Pharma downgraded by Piper Sandler with a new price target - Quantisnow

Dec 12, 2025

Insiders Who Sold Rigel Pharmaceuticals Made The Right Call As Market Cap Slides By US$97m - simplywall.st

Dec 12, 2025

Rigel Pharmaceuticals, Inc. $RIGL Shares Bought by Globeflex Capital L P - MarketBeat

Dec 12, 2025

Armistice Capital LLC Acquires 84,000 Shares of Rigel Pharmaceuticals, Inc. $RIGL - MarketBeat

Dec 12, 2025

Dec 11, 2025

Top-Rated Stocks: Rigel Pharmaceuticals Sees Composite Rating Climb To 96 - MSN

Dec 11, 2025

Dec 10, 2025

Rigel Pharmaceuticals Reports Promising Phase 1b Study Results - TipRanks

Dec 10, 2025

Rigel Pharmaceuticals Inc Presents Updated Data from Phase 1b Study on R289 - TradingView — Track All Markets

Dec 10, 2025

Dec 09, 2025

Rigel Pharmaceuticals Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Dec 09, 2025

Dec 08, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 13.7%Should You Sell? - MarketBeat

Dec 08, 2025

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛

Dec 08, 2025

Dec 07, 2025